FIG 1.
rwPFS and OS among patients who received sotorasib for advanced KRAS G12C-mutant Non–Small Cell lung cancer. Kaplan-Meier curve of (A) rwPFS and (B) OS among evaluable patients. Tick marks indicate censored data. OS, overall survival; rwPFS, real-world progression-free survival.